English
Our multidisciplinary teams with 20 years of combined expertise in the pharmaceutical industry and emerging markets. We thrive at the intersection of innovation and experience, transcending boundaries to deliver cutting-edge solutions.
Pharmaceutical Institute, a Moroccan pharmaceutical company, with a global presence, is a subsidiary of Kelix bio, a specialty generics company.
Who We Are …
A leading Moroccan specialty generics company, with a global presence, and subsidiary of the Kelix bio group, which operates across the Middle East Asia, Africa and South East Asia, through subsidiaries and distributor network.
Our sprawling manufacturing site spans 30,000 square meters, proudly holding national and international certifications.
Our employees of over 400 dedicated team members is committed to provide unwavering support to healthcare professionals and patients to shape a healthier world
With a legacy forged over three decades, our reputation is built on a steadfast commitment to care, compassion, and continuous improvement.
Multidisciplinary teams
Investments
in skills
Our commitment goes beyond medicines – it is an investment in skills, know-how, and technology transfers.
Investment
plan
We have ambitions to expand our capabilities into injectables and biological products.
Registration in Morocco
We have set our sigh on registering the specialty portfolio of our parent group in Morocco.
Welcome to Phi by KELIX bio
Our Vision …
Build a specialty generics pharmaceutical company focused on emerging markets with high quality products at affordable prices through innovation and cost leadership.
Our Ambitions ...
Facilitate access to care
In Morocco as well as in emerging markets, in innovative, specialty therapeutic areas with the highest quality standards.
Maintain our leadership
On existing therapeutic areas of cardiovascular, central nervous system and urology
alignment with the health policies of the Kingdom
Through the promotion of access to generic drugs, localized production and technology transfer, but also through making a significant contribution to the health insurance generalization project.
Anchor our expertise
On products as specialized as injectables and biologics to facilitate access.
News & Events
17th - CARDIOLOGY SPRING EDITION
From 4 to 6 May at the Savoy hotel in Marrakech the 17th edition of the Printemps de la Cardiologie, Our presence at the congress was marked...
Read More
SMACOT TRAUMATOLOGY CONGRESS
From 27 to 29 April the participation of Phi by Kelix Bio in the two major meetings of the pain range, namely the SMACOT congresses...
Read More
OFFICINO EXPO - 2023
From 24 to 25 FEBRUARY 2023 in Marrakech: We are committed as players in the pharmaceutical industry. We are committed to our commitment...
Read More
SMR RHUMATOLOGUE CONGRESS
From 05 to 07 April the participation of Phi by Kelix Bio in the two major meetings of the pain range, namely the SMR congresses...
Read More
